Wolverine Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Wolverine Trading’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,700	Closed	-$392K	–	6815
2024 Q4	$392K	Sell	4,700 -3,500	-43%	-$288K	0.01%	3706
2024 Q3	$601K	Buy	+8,200	New	+$616K	0.02%	2877
2024 Q2	–	Sell	-6,700	Closed	-$464K	–	6114
2024 Q1	$464K	Sell	6,700 -13,300	-67%	-$914K	﹤0.01%	2914
2023 Q4	$1.43M	Buy	+20,000	New	+$1.15M	0.01%	1955
2023 Q2	–	Sell	-6,200	Closed	-$348K	–	6014
2023 Q1	$348K	Sell	6,200 -100	-2%	-$4.83K	0.01%	2870
2022 Q4	$333K	Sell	6,300 -7,700	-55%	-$386K	0.01%	2679
2022 Q3	$634K	Buy	+14,000	New	+$731K	0.02%	2393
2022 Q2	–	Sell	-6,100	Closed	-$368K	–	6765
2022 Q1	$368K	Sell	6,100 -25,600	-81%	-$1.33M	0.01%	3647
2021 Q4	$1.65M	Buy	31,700 +10,500	+50%	+$441K	0.02%	2063
2021 Q3	$759K	Buy	21,200 +15,000	+242%	+$521K	0.02%	3357
2021 Q2	$246K	Buy	+6,200	New	+$229K	0.01%	4724
2021 Q1	–	Sell	-16,200	Closed	-$522K	–	7087
2020 Q4	$522K	Sell	16,200 -11,000	-40%	-$289K	0.01%	3119
2020 Q3	$695K	Sell	27,200 -2,800	-9%	-$63.9K	0.03%	2446
2020 Q2	$755K	Sell	30,000 -5,100	-15%	-$103K	0.04%	2294
2020 Q1	$555K	Sell	35,100 -54,800	-61%	-$1.19M	0.02%	2547
2019 Q4	$3.03M	Buy	89,900 +65,900	+275%	+$791K	0.06%	1503
2019 Q3	$180K	Sell	24,000 -21,800	-48%	-$209K	0.01%	3643
2019 Q2	$594K	Sell	45,800 -31,500	-41%	-$404K	0.02%	2537
2019 Q1	$942K	Buy	77,300 +51,100	+195%	+$653K	0.03%	2133
2018 Q4	$295K	Sell	26,200 -7,100	-21%	-$115K	0.01%	3216
2018 Q3	$723K	Sell	33,300 -24,300	-42%	-$508K	0.02%	2692
2018 Q2	$1.21M	Hold	57,600	–	–	0.03%	2055
2018 Q1	$1.21M	Buy	57,600 +23,000	+66%	+$448K	0.03%	2055
2017 Q4	$501K	Buy	34,600 +8,300	+32%	+$128K	0.01%	2994
2017 Q3	$415K	Buy	26,300 +5,300	+25%	+$77.8K	0.02%	2836
2017 Q2	$266K	Sell	21,000 -17,400	-45%	-$202K	0.01%	3217
2017 Q1	$624K	Buy	38,400 +6,500	+20%	+$94.1K	0.03%	2153
2016 Q4	$481K	Sell	31,900 -8,400	-21%	-$119K	0.02%	2673
2016 Q3	$621K	Sell	40,300 -3,700	-8%	-$150K	0.04%	2359
2016 Q2	$1.65M	Buy	+44,000	New	+$1.58M	0.14%	1235